Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results